欢迎来到《四川大学学报(医学版)》

随机尿钾与尿肌酐比值在判断肾性失钾中的应用价值研究

孙易红 赵炼玲 王晓书 任艳 田浩明 陈涛

孙易红, 赵炼玲, 王晓书, 等. 随机尿钾与尿肌酐比值在判断肾性失钾中的应用价值研究[J]. 四川大学学报(医学版), 2023, 54(3): 620-624. doi: 10.12182/20230560201
引用本文: 孙易红, 赵炼玲, 王晓书, 等. 随机尿钾与尿肌酐比值在判断肾性失钾中的应用价值研究[J]. 四川大学学报(医学版), 2023, 54(3): 620-624. doi: 10.12182/20230560201
SUN Yi-hong, ZHAO Lian-ling, WANG Xiao-shu, et al. Application Value of Random Urine Potassium-to-Creatinine Ratio in Diagnosing Renal Potassium Loss[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2023, 54(3): 620-624. doi: 10.12182/20230560201
Citation: SUN Yi-hong, ZHAO Lian-ling, WANG Xiao-shu, et al. Application Value of Random Urine Potassium-to-Creatinine Ratio in Diagnosing Renal Potassium Loss[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2023, 54(3): 620-624. doi: 10.12182/20230560201

随机尿钾与尿肌酐比值在判断肾性失钾中的应用价值研究

doi: 10.12182/20230560201
基金项目: 四川大学华西医院学科发展1·3·5工程项目(No. ZYGD18022)资助
详细信息
    通讯作者:

    E-mail:dr.chentao@qq.com

Application Value of Random Urine Potassium-to-Creatinine Ratio in Diagnosing Renal Potassium Loss

Funds: Acknowledgement. This study was supported by a 1·3·5 Discipline Development Project of West China Hospital of Sichuan University (ZYGD18022)
More Information
  • 摘要:   目的   分析随机尿钾/尿肌酐(rUK/Ucr)在判断肾性失钾中的应用价值。   方法   纳入2017–2021年诊断为低钾血症患者〔包括肾性失钾(373例)、非肾性失钾(83例)〕、血钾正常(358例)的住院患者。收集临床资料,分析rUK/Ucr与24 h尿钾(24 hUK)的相关性;针对低钾血症患者绘制受试者工作特征(ROC)曲线,分析rUK/Ucr判断肾性失钾的价值。   结果   血钾在血钾正常组、肾性失钾组、非肾性失钾组依次降低(P<0.01)。肾性失钾组24 hUK、rUK/Ucr大于非肾性失钾及血钾正常组(P<0.01)。rUK/Ucr与24 hUK呈低到中度相关。24 hUK、rUK/Ucr判断肾性失钾的曲线下面积(AUC)分别为0.73、0.71,rUK/Ucr判断肾性失钾的最佳切点为3.4时,灵敏度为67.59%,特异度为67.53%。   结论   rUK/Ucr与24 hUK的相关性一般,rUK/Ucr预测肾性失钾的价值与24 hUK相当。在无法获取24 h尿液标本时,可推荐使用rUK/Ucr替代24 hUK来初步判断是否存在肾性失钾,其最佳诊断切点为3.4。
  • 图  1  rUK/Ucr及24 hUK判断肾性失钾的ROC曲线图

    Figure  1.  ROC curves of rUK/Ucr and 24 hUK for renal potassium loss

    表  1  血钾正常组、肾性失钾组、非肾性失钾组之间临床生化指标的差异性比较

    Table  1.   The differences in clinical biochemical indices among normal potassium group, renal potassium loss group, and non-renal potassium loss group

    IndexNormal potassium group (n=358)Renal potassium loss group (n=373)Non-renal potassium loss group (n=83)
    Male/% 46.09 49.33 38.55
    Age/yr. 50.30±14.81 50.64±12.45 48.02±9.57
    BMI/(kg/m2) 24.46±3.82 24.61±3.78 24.00±3.04
    SBP/mmHg 158±32 174±26**, † 163±30
    DBP/mmHg 96±22 106±16** 100±23
    Synchronous potassium/(mmol/L) 3.98±0.30 3.20±0.20** 2.55±0.19**, †
    Glu/(mmol/L) 5.0 (4.5, 6.1) 5.0 (4.6, 5.6) 5.7 (4.9, 8.8)**, †
    TC/(mmol/L) 4.44±1.10 4.28±0.89*, † 4.31±0.81
    TG/(mmol/L) 1.3 (1.0, 2.0) 1.3 (0.8, 1.8) 1.5 (0.9, 2.3)
    LDL-C/(mmol/L) 2.59±0.86 2.47±0.80 2.60±0.61
    eGFR/(mL/[min·1.73 m2]) 98.75±20.93 98.27±21.38 97.37±23.49
    Synchronous 24 hUK/mmol 37.8 (29.3, 49.3) 45.3 (34.7, 61.2)** 31.4 (24.4, 38.0)**, †
    rUK/Ucr 3.5 (2.5, 4.8) 4.2 (3.0, 6.5)** 2.9 (2.1, 4.0)*, †
     * P<0.05, ** P<0.01, vs. normal potassium group; P<0.05, P<0.01, vs. renal potassium loss group. 1 mmHg=0.133 kPa. BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; Glu: glucose; TC: total cholesterol; TG: triglyceride; LDL-C: low density lipoprotein cholesterol; eGFR: estimated glomerular filtration rate.
    下载: 导出CSV

    表  2  rUK/Ucr与24 hUK的Spearman相关分析

    Table  2.   The Spearman correlation between rUK/Ucr and 24 hUK

    GroupSpearman r
    Total (n=814) 0.46
    Serum potassium/(mmol/L)
     ≥3.5 (n=358) 0.46
     <3.5 (n=456) 0.46
      3-3.49 (n=298) 0.46
      <3 (n=158) 0.39
    Renal potassium loss
     Yes (n=373) 0.45
     No (n=83) 0.66
    下载: 导出CSV

    表  3  rUK/Ucr、24 hUK诊断肾性失钾的ROC曲线参数

    Table  3.   Parameters of ROC curves for the rUK/Ucr and 24 hUK

    Parameter24 hUK rUK/Ucr
    AUC 0.73 0.71
    Optimum cutoff point 38 3.4
    Sensitivity 64.44% 67.56%
    Specificity 75% 67.53%
    False positive rate 25% 32.74%
    False negative rate 35.56% 32.41%
    Positive likelihood ratio 2.58 2.08
    Negative likelihood ratio 0.47 0.48
    Positive predictive value 91.38% 85.38%
    Negative predictive value 33.9% 42.62%
    Accuracy 66.5% 67.58%
     AUC: area under the curve.
    下载: 导出CSV
  • [1] PALMER B F, CLEGG D J. Physiology and pathophysiology of potassium homeostasis. Adv Physiol Educ,2016,40(4): 480–490. doi: 10.1152/advan.00121.2016
    [2] LIN S H, LIN Y F, CHEN D T, et al. Laboratory tests to determine the cause of hypokalemia and paralysis. Arch Intern Med,2004,164(14): 1561–1566. doi: 10.1001/archinte.164.14.1561
    [3] BARDAK S, TURGUTALP K, HARI H, et al. Community-acquired hypokalemia in elderly patients: related factors and clinical outcomes. Int Urol Nephrol,2017,49(3): 483–489. doi: 10.1007/s11255-016-1489-3
    [4] YALAMANCHILI H B, CALP-INAL S, ZHOU X J, et al. Hypokalemic nephropathy. Kidney Int Rep,2018,3(6): 1482–1488. doi: 10.1016/j.ekir.2018.07.014
    [5] JI C, SYKES L, PAUL C, et al. Systematic review of studies comparing 24-hour and spot urine collections for estimating population salt intake. Rev Panam Salud Publica,2012,32(4): 307–315. doi: 10.1590/s1020-49892012001000010
    [6] JEDRUSIK P, SYMONIDES B, GACIONG Z. Comparison of three formulas to estimate 24-hour urinary sodium and potassium excretion in patients hospitalized in a hypertension unit. J Am Soc Hypertens,2018,12(6): 457–469. doi: 10.1016/j.jash.2018.03.010
    [7] JEDRUSIK P, SYMONIDES B, GRYGLAS A, et al. Diagnostic value of potassium level in a spot urine sample as an index of 24-hour urinary potassium excretion in unselected patients hospitalized in a hypertension unit. PLoS One,2017,12(6): e0180117. doi: 10.1371/journal.pone.0180117
    [8] LI J, MA H, LEI Y, et al. Diagnostic value of parameters from a spot urine sample for renal potassium loss in hypokalemia. Clin Chim Acta,2020,511: 221–226. doi: 10.1016/j.cca.2020.10.024
    [9] 林春妹. 即时尿钾/尿肌酐在低钾血症诊治中可作为24 hUK的替代指标. 沈阳: 中国医科大学, 2017.
    [10] WEISS J N, QU Z, SHIVKUMAR K. Electrophysiology of hypokalemia and hyperkalemia. Circ Arrhythm Electrophysiol,2017,10(3): e004667. doi: 10.1161/CIRCEP.116.004667
    [11] DUBOSE T D, Jr. Regulation of potassium homeostasis in CKD. Adv Chronic Kidney Dis,2017,24(5): 305–314. doi: 10.1053/j.ackd.2017.06.002
    [12] LIN S H, LIN Y F, HALPERIN M L. Hypokalaemia and paralysis. QJM,2001,94(3): 133–139. doi: 10.1093/qjmed/94.3.133
    [13] 王天, 陈桃, 蔡琪, 等. 非布司他联合枸橼酸钾缓释片治疗痛风及高尿酸血症肾结石疗效. 实用医学杂志,2020,36(2): 224–228. doi: CNKI:SUN:SYYZ.0.2020-02-020
  • 加载中
图(1) / 表(3)
计量
  • 文章访问数:  17
  • HTML全文浏览量:  2
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-09-27
  • 修回日期:  2023-04-14
  • 网络出版日期:  2023-05-20
  • 刊出日期:  2023-05-20

目录

    /

    返回文章
    返回